Literature DB >> 34153932

Validation of the plasmid study to relate DNA damaging effects of radionuclides to those from external beam radiotherapy.

Elise Verger1, Jordan Cheng1, Vittorio de Santis1, Madeleine Iafrate1, Jessica A Jackson1, Cinzia Imberti1, Gilbert O Fruhwirth2, Philip J Blower1, Michelle T Ma1, Daniel R Burnham3, Samantha Y A Terry4.   

Abstract

INTRODUCTION: The biological consequences of absorbed radiation doses are ill-defined for radiopharmaceuticals, unlike for external beam radiotherapy (EBRT). A reliable assay that assesses the biological consequences of any radionuclide is much needed. Here, we evaluated the cell-free plasmid DNA assay to determine the relative biological effects of radionuclides such as Auger electron-emitting [67Ga]GaCl3 or [111In]InCl3 compared to EBRT.
METHODS: Supercoiled pBR322 plasmid DNA (1.25 or 5 ng/μL) was incubated with 0.5 or 1 MBq [67Ga]GaCl3 or [111In]InCl3 for up to 73 h or was exposed to EBRT (137Cs; 5 Gy/min; 0-40 Gy). The induction of relaxed and linear plasmid DNA, representing single and double strand breaks, respectively, was assessed by gel electrophoresis. Chelated forms of 67Ga were also investigated using DOTA and THP. Topological conversion rates for supercoiled-to-relaxed (ksrx) or relaxed-to-linear (krlx) DNA were obtained by fitting a kinetic model.
RESULTS: DNA damage increased both with EBRT dose and incubation time for [67Ga]GaCl3 and [111In]InCl3. Damage caused by [67Ga]GaCl3 decreased when chelated. [67Ga]GaCl3 proved more damaging than [111In]InCl3; 1.25 ng/μL DNA incubated with 0.5 MBq [67Ga]GaCl3 for 2 h led to a 70% decrease of intact plasmid DNA as opposed to only a 19% decrease for [111In]InCl3. For both EBRT and radionuclides, conversion rates were slower for 5 ng/μL than 1.25 ng/μL plasmid DNA. DNA damage caused by 1 Gy EBRT was the equivalent to damage caused by 0.5 MBq unchelated [67Ga]GaCl3 and [111In]InCl3 after 2.05 ± 0.36 and 9.3 ± 0.77 h of incubation, respectively.
CONCLUSIONS: This work has highlighted the power of the plasmid DNA assay for a rapid determination of the relative biological effects of radionuclides compared to external beam radiotherapy. It is envisaged this approach will enable the systematic assessment of imaging and therapeutic radionuclides, including Auger electron-emitters, to further inform radiopharmaceutical design and application.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Auger electrons; Biological effects; External beam radiation; Radiobiology; Radionuclides

Mesh:

Substances:

Year:  2021        PMID: 34153932      PMCID: PMC7611685          DOI: 10.1016/j.nucmedbio.2021.06.004

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  51 in total

1.  Strand breaks in plasmid DNA after positional changes of Auger electron-emitting iodine-125: direct compared to indirect effects.

Authors:  A I Kassis; R S Harapanhalli; S J Adelstein
Journal:  Radiat Res       Date:  1999-11       Impact factor: 2.841

2.  Therapeutic potential of 5-[125I]iodo-2'-deoxyuridine and methotrexate in the treatment of advanced neoplastic meningitis.

Authors:  Amin I Kassis; Agop M Kirichian; Ketai Wang; Elham Safaie Semnani; S James Adelstein
Journal:  Int J Radiat Biol       Date:  2004 Nov-Dec       Impact factor: 2.694

3.  ICRP Publication 107. Nuclear decay data for dosimetric calculations.

Authors:  K Eckerman; A Endo
Journal:  Ann ICRP       Date:  2008

Review 4.  Radiation oncology in the era of precision medicine.

Authors:  Michael Baumann; Mechthild Krause; Jens Overgaard; Jürgen Debus; Søren M Bentzen; Juliane Daartz; Christian Richter; Daniel Zips; Thomas Bortfeld
Journal:  Nat Rev Cancer       Date:  2016-03-18       Impact factor: 60.716

5.  Radiotoxicity of thallium-201 in mouse testes: inadequacy of conventional dosimetry.

Authors:  D V Rao; G F Govelitz; K S Sastry
Journal:  J Nucl Med       Date:  1983-02       Impact factor: 10.057

6.  Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen.

Authors:  Il Minn; Ying Chen; Ana P Kiess; Robert Hobbs; George Sgouros; Ronnie C Mease; Mrudula Pullambhatla; Colette J Shen; Catherine A Foss; Martin G Pomper
Journal:  J Nucl Med       Date:  2015-07-16       Impact factor: 10.057

7.  Strand breaks in plasmid DNA following positional changes of Auger-electron-emitting radionuclides.

Authors:  S J Adelstein; A I Kassis
Journal:  Acta Oncol       Date:  1996       Impact factor: 4.089

8.  Alpha emitter radium-223 and survival in metastatic prostate cancer.

Authors:  C Parker; S Nilsson; D Heinrich; S I Helle; J M O'Sullivan; S D Fosså; A Chodacki; P Wiechno; J Logue; M Seke; A Widmark; D C Johannessen; P Hoskin; D Bottomley; N D James; A Solberg; I Syndikus; J Kliment; S Wedel; S Boehmer; M Dall'Oglio; L Franzén; R Coleman; N J Vogelzang; C G O'Bryan-Tear; K Staudacher; J Garcia-Vargas; M Shan; Ø S Bruland; O Sartor
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

9.  Evaluation of Acridine Orange Derivatives as DNA-Targeted Radiopharmaceuticals for Auger Therapy: Influence of the Radionuclide and Distance to DNA.

Authors:  Edgar Pereira; Letícia do Quental; Elisa Palma; Maria Cristina Oliveira; Filipa Mendes; Paula Raposinho; Isabel Correia; João Lavrado; Salvatore Di Maria; Ana Belchior; Pedro Vaz; Isabel Santos; António Paulo
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

10.  In Vivo PET Tracking of 89Zr-Labeled Vγ9Vδ2 T Cells to Mouse Xenograft Breast Tumors Activated with Liposomal Alendronate.

Authors:  Francis Man; Lindsay Lim; Alessia Volpe; Alberto Gabizon; Hilary Shmeeda; Benjamin Draper; Ana C Parente-Pereira; John Maher; Philip J Blower; Gilbert O Fruhwirth; Rafael T M de Rosales
Journal:  Mol Ther       Date:  2018-10-16       Impact factor: 11.454

View more
  1 in total

1.  Searching for a Paradigm Shift in Auger-Electron Cancer Therapy with Tumor-Specific Radiopeptides Targeting the Mitochondria and/or the Cell Nucleus.

Authors:  Célia Fernandes; Elisa Palma; Francisco Silva; Ana Belchior; Catarina I G Pinto; Joana F Guerreiro; Hugo M Botelho; Filipa Mendes; Paula Raposinho; António Paulo
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.